Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3735 | 1050 | 33.9 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
127 | 3 | OXYTOCIN//BEHAVIORAL SCIENCES//VASOPRESSIN | 67291 |
3735 | 2 | UROTENSIN II//GPR14//UT RECEPTOR | 1050 |
14747 | 1 | UROTENSIN II//GPR14//UT RECEPTOR | 752 |
31588 | 1 | 5 AMINO EXO 3 AZATRICYCLO52102 6DECANE 4 ONE//ADRENERGIC DAMAGE//BRIDGE COMPOUNDS | 151 |
36161 | 1 | EVENING TREATMENT PROGRAM//AGGRESSION SCALE//ASSAULTIVE MEN | 85 |
37283 | 1 | AMPLITUDAL SPECTRUM//CIRCULATION PARAMETERS//NIR PHOTOPLETHYSMOGRAPHY | 62 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | UROTENSIN II | authKW | 7869933 | 29% | 90% | 302 |
2 | GPR14 | authKW | 988711 | 3% | 100% | 34 |
3 | UT RECEPTOR | authKW | 817864 | 3% | 94% | 30 |
4 | UROTENSIN | authKW | 807502 | 4% | 73% | 38 |
5 | UROTENSIN II RELATED PEPTIDE | authKW | 611937 | 2% | 96% | 22 |
6 | UROTENSIN II RECEPTOR | authKW | 495884 | 2% | 95% | 18 |
7 | URANTIDE | authKW | 494356 | 2% | 100% | 17 |
8 | HUMAN UROTENSIN II | authKW | 378037 | 1% | 100% | 13 |
9 | PALOSURAN | authKW | 322112 | 1% | 92% | 12 |
10 | CAUDAL NEUROSECRETORY SYSTEM | authKW | 316640 | 1% | 78% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 2486 | 20% | 0% | 205 |
2 | Pharmacology & Pharmacy | 2151 | 28% | 0% | 292 |
3 | Peripheral Vascular Diseases | 524 | 7% | 0% | 76 |
4 | Biochemistry & Molecular Biology | 288 | 18% | 0% | 187 |
5 | Chemistry, Medicinal | 264 | 5% | 0% | 57 |
6 | Physiology | 261 | 6% | 0% | 67 |
7 | Cardiac & Cardiovascular System | 261 | 7% | 0% | 78 |
8 | Medicine, Research & Experimental | 231 | 7% | 0% | 70 |
9 | Medicine, General & Internal | 90 | 6% | 0% | 63 |
10 | Biology | 65 | 3% | 0% | 31 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOVASC UROGENITAL EXCELLENCE DRUG DISCO | 199749 | 2% | 30% | 23 |
2 | CARDIOVASC PHARMACOL UW2510 | 87239 | 0% | 100% | 3 |
3 | ETUD MOL PHARMACOL PEPTIDES | 69784 | 1% | 40% | 6 |
4 | DIS GRP CARDIOVASC | 60577 | 0% | 42% | 5 |
5 | EVENING TREATMENT PROGRAM | 58159 | 0% | 100% | 2 |
6 | LEAD GENERAT CHEM | 58159 | 0% | 100% | 2 |
7 | CARDIOVASC UROGENITAL CEDD | 42293 | 0% | 36% | 4 |
8 | BIOSTRUCT BIOIMAGING CNR | 38772 | 0% | 67% | 2 |
9 | PHARMACOL THER EUT GRP ANAESTHESIA CRIT CA | 38772 | 0% | 67% | 2 |
10 | SANTE RECH MED U982 | 38772 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PEPTIDES | 28709 | 9% | 1% | 93 |
2 | GENERAL AND COMPARATIVE ENDOCRINOLOGY | 5565 | 4% | 0% | 39 |
3 | JOURNAL OF CLINICAL SURGERY-APPLIED PHYSIOLOGY & METABOLISM | 3417 | 0% | 6% | 2 |
4 | BRITISH JOURNAL OF PHARMACOLOGY | 2075 | 3% | 0% | 36 |
5 | JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE SECTION C-BIOLOGICAL SCIENCES | 1614 | 0% | 6% | 1 |
6 | INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY | 1538 | 1% | 0% | 14 |
7 | JOURNAL OF MEDICAL BIOGRAPHY | 1386 | 0% | 2% | 3 |
8 | UNIVERSITY OF DETROIT LAW REVIEW | 1320 | 0% | 5% | 1 |
9 | REGULATORY PEPTIDES | 1184 | 1% | 0% | 14 |
10 | ANALES DE QUIMICA SERIE C-QUIMICA ORGANICA Y BIOQUIMICA | 1130 | 0% | 1% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | UROTENSIN II | 7869933 | 29% | 90% | 302 | Search UROTENSIN+II | Search UROTENSIN+II |
2 | GPR14 | 988711 | 3% | 100% | 34 | Search GPR14 | Search GPR14 |
3 | UT RECEPTOR | 817864 | 3% | 94% | 30 | Search UT+RECEPTOR | Search UT+RECEPTOR |
4 | UROTENSIN | 807502 | 4% | 73% | 38 | Search UROTENSIN | Search UROTENSIN |
5 | UROTENSIN II RELATED PEPTIDE | 611937 | 2% | 96% | 22 | Search UROTENSIN+II+RELATED+PEPTIDE | Search UROTENSIN+II+RELATED+PEPTIDE |
6 | UROTENSIN II RECEPTOR | 495884 | 2% | 95% | 18 | Search UROTENSIN+II+RECEPTOR | Search UROTENSIN+II+RECEPTOR |
7 | URANTIDE | 494356 | 2% | 100% | 17 | Search URANTIDE | Search URANTIDE |
8 | HUMAN UROTENSIN II | 378037 | 1% | 100% | 13 | Search HUMAN+UROTENSIN+II | Search HUMAN+UROTENSIN+II |
9 | PALOSURAN | 322112 | 1% | 92% | 12 | Search PALOSURAN | Search PALOSURAN |
10 | CAUDAL NEUROSECRETORY SYSTEM | 316640 | 1% | 78% | 14 | Search CAUDAL+NEUROSECRETORY+SYSTEM | Search CAUDAL+NEUROSECRETORY+SYSTEM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VAUDRY, H , LEPRINCE, J , CHATENET, D , FOURNIER, A , LAMBERT, DG , LE MEVEL, JC , OHLSTEIN, EH , SCHWERTANI, A , TOSTIVINT, H , VAUDRY, D , (2015) INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY. XCII. UROTENSIN II, UROTENSIN II-RELATED PEPTIDE, AND THEIR RECEPTOR: FROM STRUCTURE TO FUNCTION.PHARMACOLOGICAL REVIEWS. VOL. 67. ISSUE 1. P. 214 -258 | 316 | 86% | 4 |
2 | ROSS, B , MCKENDY, K , GIAID, A , (2010) ROLE OF UROTENSIN II IN HEALTH AND DISEASE.AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY. VOL. 298. ISSUE 5. P. R1156 -R1172 | 130 | 94% | 53 |
3 | VAUDRY, H , DO REGO, JC , LE MEVEL, JC , CHATENET, D , TOSTIVINT, H , FOURNIER, A , TONON, MC , PELLETIER, G , CONLON, JM , LEPRINCE, J , (2010) UROTENSIN II, FROM FISH TO HUMAN.PHYLOGENETIC ASPECTS OF NEUROPEPTIDES: FROM INVERTEBRATES TO HUMANS. VOL. 1200. ISSUE . P. 53-66 | 120 | 94% | 36 |
4 | WATANABE, T , ARITA, S , SHIRAISHI, Y , SUGURO, T , SAKAI, T , HONGO, S , MIYAZAKI, A , (2009) HUMAN UROTENSIN II PROMOTES HYPERTENSION AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASES.CURRENT MEDICINAL CHEMISTRY. VOL. 16. ISSUE 5. P. 550 -563 | 118 | 94% | 20 |
5 | TOLLE, M , VAN DER GIET, M , (2008) CARDIORENOVASCULAR EFFECTS OF UROTENSIN II AND THE RELEVANCE OF THE UT RECEPTOR.PEPTIDES. VOL. 29. ISSUE 5. P. 743-763 | 118 | 91% | 28 |
6 | MARYANOFF, BE , KINNEY, WA , (2010) UROTENSIN-II RECEPTOR MODULATORS AS POTENTIAL DRUGS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 53. ISSUE 7. P. 2695-2708 | 105 | 92% | 22 |
7 | ONG, KL , LAM, KSL , CHEUNG, BMY , (2005) UROTENSIN II: ITS FUNCTION IN HEALTH AND ITS ROLE IN DISEASE.CARDIOVASCULAR DRUGS AND THERAPY. VOL. 19. ISSUE 1. P. 65-75 | 98 | 92% | 59 |
8 | ZHU, YC , ZHU, YZ , MOORE, PK , (2006) THE ROLE OF UROTENSIN II IN CARDIOVASCULAR AND RENAL PHYSIOLOGY AND DISEASES.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 148. ISSUE 7. P. 884 -901 | 88 | 99% | 44 |
9 | LEPRINCE, J , CHATENET, D , DUBESSY, C , FOURNIER, A , PFEIFFER, B , SCALBERT, E , RENARD, P , PACAUD, P , OULYADI, H , SEGALAS-MILAZZO, I , ET AL (2008) STRUCTURE-ACTIVITY RELATIONSHIPS OF UROTENSIN II AND URP.PEPTIDES. VOL. 29. ISSUE 5. P. 658-673 | 83 | 91% | 17 |
10 | MCDONALD, J , BATUWANGALA, M , LAMBERT, DG , (2007) ROLE OF UROTENSIN II AND ITS RECEPTOR IN HEALTH AND DISEASE.JOURNAL OF ANESTHESIA. VOL. 21. ISSUE 3. P. 378 -389 | 80 | 96% | 20 |
Classes with closest relation at Level 2 |